Celgene Lunch & Learn

Pharma today faces many sustainability challenges as medicines are becoming more personalized, competition is stiff, and healthcare spending is under constant scrutiny. While the science in early research has made immense progress over the past decade, the way pharma conducts clinical trials – a critical path and lengthy activity – has barely evolved. Celgene will discuss how companies are tackling this bottleneck with a combination of human centric design and advanced analytics, and why there needs to be more innovation in this area.

Peter Ray
Peter is Executive Director of Corporate Strategy at Kellogg. He is a seasoned industry executive with deep knowledge of the R&D productivity and sustainability challenges facing the industry. At Celgene, Peter supports senior leadership to shape and evolve the company's corporate strategy and long-range plans, and provides frameworks, analytics, and insights on portfolio prioritization, innovation sourcing, and R&D strategy and productivity. He received his MBA from Stanford University and BA in Government/East Asian Studies from Harvard University.

Zoe Li
Zoe graduated from Kellogg (MMM) in 2018 and recently joined Celgene as the innovation lead in the global clinical R&D group. In this role, Zoe is responsible for setting the strategy for innovation as they relate to clinical trials and guide business teams through user research, proof of concepts, and implementation scaling. Prior to Kellogg, Zoe was a consultant in IBM's Interactive Experience practice.

Healthcare Club | Website | View More Events